Previous 10 | Next 10 |
PORTLAND, Maine, Dec. 15, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve the he...
ImmuCell Corporation (ICCC) Q3 2020 Earnings Conference Call November 13, 2020, 09:00 AM ET Company Participants Joe Diaz - Lytham Partners Michael Brigham - President and CEO Conference Call Participants Sam Rebotsky - SER Asset Management Presentation Operator Good morning and welcome to th...
The following slide deck was published by ImmuCell Corporation in conjunction with their 2020 Q3 earnings call. For further details see: ImmuCell Corporation 2020 Q3 - Results - Earnings Call Presentation
ImmuCell (ICCC): Q3 GAAP EPS of -$0.04 beats by $0.04.Revenue of $3.72M (+25.3% Y/Y) beats by $0.45M.Press Release For further details see: ImmuCell EPS beats by $0.04, beats on revenue
PORTLAND, Maine, Nov. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve th...
PORTLAND, Maine, Nov. 05, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve th...
ImmuCell (ICCC) reports Q3 total product sales increased by 25% to $3.7M vs. $3.27M consensus.“We reduced the backlog of orders that was worth ~$1.4M as of March 31, 2020 and ~$945,000 as of June 30, 2020 to ~$130,000 as of September 30, 2020,” concluded Mr. Brigham.Source: Pres...
PORTLAND, Maine, Oct. 06, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and practical products that improve th...
The following slide deck was published by ImmuCell Corporation in conjunction with their 2020 Q2 earnings Read more ...
ImmuCell Corporation (ICCC) Q2 2020 Results Earnings Conference Call August 13, 2020, 9:00 am ET Company Participants Michael Brigham - President, Chief Executive Officer, Director Joe Diaz - Investor Relations, Managing Partner at Lytham Partners Conference Call Participants ...
News, Short Squeeze, Breakout and More Instantly...
PORTLAND, Maine , June 05, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the he...
PORTLAND, Maine, May 14, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health an...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...